Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 26,076–26,100 of 27,380 studies, newest first · page 1044 of 1096.

October 1997 14

  1. 1997-10-01

    Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias

    ✓ Peer-reviewed Vascular contributions Neurology

    Key finding: The mean HIS (+/- SD) was 5.4 +/- 4.5 and differed significantly among the groups (AD, 3.1 +/- 2.5; MID, 10.5 +/- 4.1; mixed, 7.7 +/- 4.3). +3 more findings

  2. 1997-10-01
  3. 1997-10-01

    The need for research on dementia in developing countries

    ✓ Peer-reviewed Risk factors Tropical Medicine & International Health

    Key finding: Although most older people live in developing countries, little research has been carried out in those settings. +4 more findings

  4. 1997-10-01
  5. 1997-10-01

    Subjective memory complaints in the elderly: depressive symptoms and future dementia

    ✓ Peer-reviewed Cognitive tests and assessment The British journal of psychiatry : the journal of mental science

    Key finding: Population studies indicate that subjective memory complaints by elderly people are correlated with cognitive performance. +3 more findings

  6. 1997-10-01

    Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure

    ✓ Peer-reviewed Cognitive tests and assessment Journal of neurology, neurosurgery, and psychiatry

    Key finding: Cognitive impairment has been reported in middle aged patients with end stage heart failure. +3 more findings

  7. 1997-10-01

    Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins

    ✓ Peer-reviewed Risk genes beyond APOE Neuron

    Key finding: In a variety of experimental in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrillogenic Abeta1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients. +2 more findings

  8. 1997-10-01

    [The apolipoprotein E genotype and Down's syndrome]

    ✓ Peer-reviewed Down syndrome and Alzheimer's Revista clinica espanola

    Key finding: Dementia in Alzheimer disease has been associated with the presence of genotype epsilon 4/epsilon 4 in apolipoprotein E (apo E). +1 more finding

  9. 1997-10-01

    Evidence against increased oxidative DNA-damage in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience letters

    Key finding: We measured the oxidized nucleoside, 8-hydroxy-2'-deoxyguanosine (8-OHdG), in nuclear DNA (nDNA) isolated from four different regions of cerebral cortex and cerebellum in 10 adult DS and 10 Alzheimer's disease (AD) patients compared to normal controls. +2 more findings

  10. 1997-10-01

    Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

    ✓ Peer-reviewed Getting a diagnosis JAMA

    Key finding: Alzheimer disease is progressive and irreversible, but pharmacologic therapies for cognitive impairment and nonpharmacologic and pharmacologic treatments for the behavioral problems associated with dementia can enhance quality of life.

  11. 1997-10-01

    A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

    ✓ Peer-reviewed Treatments JAMA

    Key finding: EGb was safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year. +4 more findings

  12. 1997-10-01

    Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice

    ✓ Peer-reviewed Genetics Human molecular genetics

    Key finding: Expression of SOD1 transgenes is protective, suggesting involvement of oxidative damage in premature death, but ablation of Apoe had no significant effect.

  13. 1997-10-01
  14. 1997-10-01

    Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

    ✓ Peer-reviewed Genetics JAMA

    Key finding: Among Caucasian subjects from clinic- or autopsy-based studies, the risk of AD was significantly increased for people with genotypes epsilon2/epsilon4 (OR=2.6, 95% CI=1.6-4.0), epsilon3/epsilon4 (OR=3.2, 95% CI=2.8-3.8), and epsilon4/epsilon4 (OR=14.9, 95% CI= 10.8-20.6); whereas, the ORs were decreased for people with genotypes epsilon2/epsilon2 (OR=0.6, 95% CI=0.2-2.0) and epsilon2/epsilon3 (OR=0.6, 95% CI=0.5-0.8). +1 more finding

September 1997 10

  1. 1997-09-15

    Activation of NF-?B protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration

    ✓ Peer-reviewed Disease mechanisms Journal of Neuroscience Research

    Key finding: We conclude that, by inducing production of Mn-SOD and suppressing peroxynitrite formation and membrane lipid peroxidation, NF-kappaB plays an anti-apoptotic role in neurodegenerative conditions that involve oxidative stress.

  2. 1997-09-13

    Bias in meta-analysis detected by a simple, graphical test

    ✓ Peer-reviewed How common it is BMJ

    A simple analysis of funnel plots provides a useful test for the likely presence of bias in meta-analyses, but as the capacity to detect bias will be limited when meta-analyses are based on a limited number of small trials the results from such analyses should be treated with considerable caution.

  3. 1997-09-01
  4. 1997-09-01

    Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality

    ✓ Peer-reviewed Vascular contributions Age and ageing

    Key finding: Design review and abstraction of medical records and computerized data bases from 5986 members, aged 65 years and older, of a large health maintenance organization in northern California.

  5. 1997-09-01

    Factors influencing dialysis patients' completion of advance directives

    ✓ Peer-reviewed End-of-life care American journal of kidney diseases : the official journal of the National Kidney Foundation

    Key finding: Those who did not complete the dialysis-specific living will chose not to because they were not sure what they would want done (12 of 16 patients [75%]). +4 more findings

  6. 1997-09-01

    Criteria for enrolling dementia patients in hospice

    ✓ Peer-reviewed End-of-life care Journal of the American Geriatrics Society

    Key finding: Our hospice enrollment criteria identified a group with a median survival time of 4 months and a mean survival time of 6.9 months. +2 more findings

  7. 1997-09-01

    Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides

    ✓ Peer-reviewed Risk genes beyond APOE Nature medicine

    Key finding: Proteolysis by gamma-secretase is the last processing step resulting in release of A beta. +3 more findings

  8. 1997-09-01

    A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease

    ✓ Peer-reviewed Lewy body dementia Journal of neurochemistry

    Key finding: In brain areas associated with PD, such as substantia nigra, caudate nucleus, and putamen, there was a significant increase in carbonyl levels. +1 more finding

  9. 1997-09-01
  10. 1997-09-01

    Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001).

August 1997 1

  1. 1997-08-28

Browse the library by subject, with the full score breakdown →